The FDA’s related initiatives in Process Analytic Technology (PAT) and Quality by Design (QbD) remain, nearly 20 years after their promulgation, largely unrealized. The technology exists for biopharma ...
There is a growing use of biomolecular interaction analysis in drug development to kinetically define the binding activities of molecules. ACROBiosystems provides SPR /BLI analytical services to its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback